Transaction DateRecipientSharesTypePriceValue
13th January 2021Fund V, L.P. Omega6,740Open or private sale$30.11$202,941.40
12th January 2021Fund V, L.P. Omega5,758Open or private sale$30.10$173,315.80
11th January 2021Fund V, L.P. Omega3,382Open or private sale$30.15$101,967.30
8th January 2021Fund V, L.P. Omega9,027Open or private sale$30.13$271,983.51
7th January 2021Fund V, L.P. Omega16,141Open or private sale$29.98$483,907.18
6th January 2021Fund V, L.P. Omega11,929Open or private sale$30.09$358,943.61
6th January 2021Fund V, L.P. Omega95Open or private sale$31.36$2,979.20
5th January 2021Fund V, L.P. Omega2,017Open or private sale$32.00$64,544.00
5th January 2021Fund V, L.P. Omega139Open or private sale$32.84$4,564.76
5th January 2021Fund V, L.P. Omega11,168Open or private sale$30.89$344,979.52
Morphic Holding
Morphic Holding logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.


Morphic Holding, Inc. engages in the research and development of oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline.


Ticker: MORF
Sector: Healthcare
Industry: Biotechnology
SEC Central Index Key (CIK): 1679363
Employees: 37
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals